We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLYS icon
126
Mineralys Therapeutics
MLYS
$2.25B
$2.41M 0.04%
+178,000
New +$2.58M
CPRI icon
127
Capri Holdings
CPRI
$1.83B
$2.39M 0.04%
135,000
– –
BJRI icon
128
BJ's Restaurants
BJRI
$1.42B
$2.23M 0.04%
50,000
– –
CNDT icon
129
Conduent
CNDT
$244M
$2.21M 0.04%
+836,000
New +$1.96M
SPOT icon
130
Spotify
SPOT
$103B
$2.16M 0.04%
2,816
-2,243
-44% -$1.44M
CRIS icon
131
Curis
CRIS
$9.78M
$2.09M 0.04%
44,996
-6,672
-13% -$262K
KMX icon
132
CarMax
KMX
$8.13B
$2.04M 0.04%
30,295
+15,315
+102% +$1.03M
META icon
133
Meta Platforms (Facebook)
META
$1.42T
$1.97M 0.03%
+2,675
New +$1.65M
SLDB icon
134
Solid Biosciences
SLDB
$794M
$1.95M 0.03%
+400,000
New +$1.41M
SNTI icon
135
Senti Biosciences Holdings
SNTI
$10.6M
$1.88M 0.03%
+892,207
New +$2.82M
TOON icon
136
Kartoon Studios
TOON
$35.2M
$1.84M 0.03%
2,473,801
-1,622,133
-40% -$1.12M
RMTI icon
137
Rockwell Medical
RMTI
$28.4M
$1.82M 0.03%
214,947
-21,667
-9% -$221K
KYNB
138
Kyntra Bio
KYNB
$27.2M
$1.78M 0.03%
336,000
-4,000
-1% -$29.2K
RANI icon
139
Rani Therapeutics
RANI
$87M
$1.62M 0.03%
+3,151,354
New +$2.57M
ZURA icon
140
Zura Bio
ZURA
$516M
$1.61M 0.03%
1,536,000
– –
ENLV icon
141
Enlivex Ltd
ENLV
$35.2M
$1.58M 0.03%
94,220
-24,575
-21% -$365K
MELI icon
142
Mercado Libre
MELI
$95.2B
$1.54M 0.03%
+589
New +$1.38M
CRBP icon
143
Corbus Pharmaceuticals
CRBP
$166M
$1.32M 0.02%
192,000
-58,000
-23% -$421K
ANY icon
144
Sphere 3D
ANY
$18.5M
$1.18M 0.02%
199,600
-20,893
-9% -$133K
LMFA
145
DELISTED
LM Funding America
LMFA
$1.14M 0.02%
15,916
+3,516
+28% +$145K
FDMT icon
146
4D Molecular Therapeutics
FDMT
$532M
$1.11M 0.02%
300,000
– –
ROKU icon
147
Roku
ROKU
$21.5B
$1.11M 0.02%
+12,641
New +$883K
PMN icon
148
ProMIS Neurosciences
PMN
$123M
$1.03M 0.02%
85,516
-7,877
-8% -$107K
RVPH
149
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$1.03M 0.02%
+134,600
New +$2.1M
SE icon
150
Sea Limited
SE
$65.4B
$992K 0.02%
+6,200
New +$898K
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.